๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus

โœ Scribed by J.I Herrero; J Quiroga; B Sangro; F Pardo; F Rotellar; J.A Cienfuegos; J Prieto

Book ID
117233609
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
62 KB
Volume
35
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Conversion of liver transplant recipient
Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil
โœ Herrero, J. Ignacio ;Quiroga, Jorge ;Sangro, Bruno ;Girala, Marcos ;Gรณmez-Manero ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 93 KB ๐Ÿ‘ 1 views

The management of liver transplant recipients with renal function impairment remains controversial because cyclosporine withdrawal from triple immunosuppression regimens may be followed by graft rejection. A nonnephrotoxic and powerful immunosuppressant such as mycophenolate mofetil (MMF) could allo

Long-term effects of calcineurin inhibit
Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation
โœ Caroline Crรฉput; Frederique Blandin; Benjamin Deroure; Bruno Roche; Faouzi Salib ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 1 views

Calcineurin inhibitors (CNIs) are the cornerstone of immunosuppression after liver transplantation. However, CNI treatment is frequently associated with chronic renal failure (CRF). The reduction or interruption of CNI may reduce renal failure. We prospectively studied 49 liver recipients treated wi